[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=3927292 [NCBI, ExPASy, EBI, Israel, Japan]
Faust P.L.,
Kornfeld S.,
Chirgwin J.M.;
"Cloning and sequence analysis of cDNA for human cathepsin D.";
Proc. Natl. Acad. Sci. U.S.A. 82:4910-4914(1985).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1093/nar/15.9.3773; PubMed=3588310 [NCBI, ExPASy, EBI, Israel, Japan]
Westley B.R.,
May F.E.B.;
"Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.";
Nucleic Acids Res. 15:3773-3786(1987).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2069717 [NCBI, ExPASy, EBI, Israel, Japan]
Redecker B.,
Heckendorf B.,
Grosch H.W.,
Mersmann G.,
Hasilik A.;
"Molecular organization of the human cathepsin D gene.";
DNA Cell Biol. 10:423-431(1991).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Ebert L.,
Schick M.,
Neubert P.,
Schatten R.,
Henze S.,
Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Kidney;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
DOI=10.1016/0378-1119(93)90107-E; PubMed=8262386 [NCBI, ExPASy, EBI, Israel, Japan]
May F.E.,
Smith D.J.,
Westley B.R.;
"The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point.";
Gene 134:277-282(1993).
|
[8]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
DOI=10.1210/me.8.6.693; PubMed=7935485 [NCBI, ExPASy, EBI, Israel, Japan]
Augereau P.,
Miralles F.,
Cavailles V.,
Gaudelet C.,
Parker M.,
Rochefort H.;
"Characterization of the proximal estrogen-responsive element of human cathepsin D gene.";
Mol. Endocrinol. 8:693-703(1994).
|
[9]
|
PROTEIN SEQUENCE OF 170-180.
TISSUE=Liver;
Hochstrasser D.F.,
Frutiger S.,
Paquet N.,
Bairoch A.,
Ravier F.,
Pasquali C.,
Sanchez J.-C.,
Tissot J.-D.,
Bjellqvist B.,
Vargas R.,
Appel R.D.,
Hughes G.J.;
Submitted (JUN-1992) to UniProtKB.
|
[10]
|
SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
DOI=10.1021/pr025562r; PubMed=12643545 [NCBI, ExPASy, EBI, Israel, Japan]
Basrur V.,
Yang F.,
Kushimoto T.,
Higashimoto Y.,
Yasumoto K.,
Valencia J.,
Muller J.,
Vieira W.D.,
Watabe H.,
Shabanowitz J.,
Hearing V.J.,
Hunt D.F.,
Appella E.;
"Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.";
J. Proteome Res. 2:69-79(2003).
|
[11]
|
GLYCOSYLATION AT ASN-263.
DOI=10.1038/nbt827; PubMed=12754519 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang H.,
Li X.-J.,
Martin D.B.,
Aebersold R.;
"Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.";
Nat. Biotechnol. 21:660-666(2003).
|
[12]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-263, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[13]
|
SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
DOI=10.1021/pr060363j; PubMed=17081065 [NCBI, ExPASy, EBI, Israel, Japan]
Chi A.,
Valencia J.C.,
Hu Z.-Z.,
Watabe H.,
Yamaguchi H.,
Mangini N.J.,
Huang H.,
Canfield V.A.,
Cheng K.C.,
Yang F.,
Abe R.,
Yamagishi S.,
Shabanowitz J.,
Hearing V.J.,
Wu C.,
Appella E.,
Hunt D.F.;
"Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.";
J. Proteome Res. 5:3135-3144(2006).
|
[14]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-263, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1074/mcp.M500324-MCP200; PubMed=16263699 [NCBI, ExPASy, EBI, Israel, Japan]
Lewandrowski U.,
Moebius J.,
Walter U.,
Sickmann A.;
"Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.";
Mol. Cell. Proteomics 5:226-233(2006).
|
[15]
|
X-RAY CRYSTALLOGRAPHY (3 ANGSTROMS).
TISSUE=Spleen;
PubMed=8467789 [NCBI, ExPASy, EBI, Israel, Japan]
Metcalf P.,
Fusek M.;
"Two crystal structures for cathepsin D: the lysosomal targeting signal and active site.";
EMBO J. 12:1293-1302(1993).
|
[16]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
TISSUE=Liver;
PubMed=8393577 [NCBI, ExPASy, EBI, Israel, Japan]
Baldwin E.T.,
Bhat T.N.,
Gulnik S.,
Hosur M.V.,
Sowder R.C. II,
Cachau R.E.,
Collins J.,
Silva A.M.,
Erickson J.W.;
"Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.";
Proc. Natl. Acad. Sci. U.S.A. 90:6796-6800(1993).
|
[17]
|
VARIANT VAL-58.
DOI=10.1002/1531-8249(200003)47:3<399::AID-ANA22>3.3.CO;2-X; PubMed=10716266 [NCBI, ExPASy, EBI, Israel, Japan]
Papassotiropoulos A.,
Bagli M.,
Kurz A.,
Kornhuber J.,
Forstl H.,
Maier W.,
Pauls J.,
Lautenschlager N.,
Heun R.;
"A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.";
Ann. Neurol. 47:399-403(2000).
|
[18]
|
VARIANTS CLN10 ILE-229 AND CYS-383.
DOI=10.1086/504159; PubMed=16685649 [NCBI, ExPASy, EBI, Israel, Japan]
Steinfeld R.,
Reinhardt K.,
Schreiber K.,
Hillebrand M.,
Kraetzner R.,
Bruck W.,
Saftig P.,
Gartner J.;
"Cathepsin D deficiency is associated with a human neurodegenerative disorder.";
Am. J. Hum. Genet. 78:988-998(2006).
|
|
ExPASy Home page
SIB Switzerland
